Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3337.29 | 258 / 258 | 100% | 88.96 | 230 / 230 |
liver | 100% | 1525.63 | 226 / 226 | 100% | 47.88 | 406 / 406 |
ovary | 100% | 2204.66 | 180 / 180 | 100% | 82.28 | 430 / 430 |
prostate | 100% | 2823.09 | 245 / 245 | 100% | 95.07 | 502 / 502 |
uterus | 100% | 2123.05 | 170 / 170 | 100% | 75.46 | 459 / 459 |
skin | 100% | 2581.04 | 1808 / 1809 | 100% | 64.49 | 472 / 472 |
esophagus | 100% | 1914.28 | 1444 / 1445 | 100% | 76.14 | 183 / 183 |
brain | 100% | 2583.00 | 2640 / 2642 | 100% | 92.88 | 705 / 705 |
lung | 100% | 2324.93 | 578 / 578 | 100% | 73.02 | 1154 / 1155 |
thymus | 100% | 3119.33 | 653 / 653 | 100% | 88.01 | 604 / 605 |
bladder | 100% | 2523.14 | 21 / 21 | 100% | 61.79 | 503 / 504 |
breast | 100% | 2517.67 | 459 / 459 | 100% | 86.46 | 1115 / 1118 |
kidney | 100% | 3846.74 | 89 / 89 | 100% | 68.29 | 898 / 901 |
stomach | 100% | 2155.54 | 359 / 359 | 100% | 65.26 | 285 / 286 |
intestine | 100% | 2108.20 | 966 / 966 | 99% | 63.01 | 524 / 527 |
pancreas | 99% | 1404.69 | 325 / 328 | 100% | 57.89 | 178 / 178 |
adipose | 100% | 2528.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 50.58 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.72 | 29 / 29 |
muscle | 100% | 2611.34 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1946.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 56.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 76.62 | 1 / 1 |
blood vessel | 100% | 2500.01 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2650.86 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 1306.37 | 825 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031145 | Biological process | anaphase-promoting complex-dependent catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0051301 | Biological process | cell division |
GO_0051445 | Biological process | regulation of meiotic cell cycle |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0005680 | Cellular component | anaphase-promoting complex |
GO_0005515 | Molecular function | protein binding |
Gene name | ANAPC13 |
Protein name | Anaphase-promoting complex subunit 13 (APC13) (Cyclosome subunit 13) Anaphase-promoting complex subunit 13 (Cyclosome subunit 13) |
Synonyms | hCG_1646826 |
Description | FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. . FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. . |
Accessions | ENST00000514612.5 A8K3Z6 Q9BS18 ENST00000510994.5 ENST00000354910.10 ENST00000511751.1 |